Pages that link to "Q40640219"
Jump to navigation
Jump to search
The following pages link to Phase II trial of recombinant interferon-alpha-2a and eflornithine in patients with recurrent glioma (Q40640219):
Displaying 2 items.
- The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme (Q35688316) (← links)
- Clinical importance of eflornithine (α-difluoromethylornithine) for the treatment of malignant gliomas (Q49600966) (← links)